WO2019157033A1 - Apparatus for and method of treating viral infections - Google Patents

Apparatus for and method of treating viral infections Download PDF

Info

Publication number
WO2019157033A1
WO2019157033A1 PCT/US2019/016814 US2019016814W WO2019157033A1 WO 2019157033 A1 WO2019157033 A1 WO 2019157033A1 US 2019016814 W US2019016814 W US 2019016814W WO 2019157033 A1 WO2019157033 A1 WO 2019157033A1
Authority
WO
WIPO (PCT)
Prior art keywords
electromagnetic radiation
range
emitting
light
centred
Prior art date
Application number
PCT/US2019/016814
Other languages
French (fr)
Inventor
Steve MENCANIN
Original Assignee
Mencanin Steve
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mencanin Steve filed Critical Mencanin Steve
Publication of WO2019157033A1 publication Critical patent/WO2019157033A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0624Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiation-Therapy Devices (AREA)

Abstract

The invention relates to an apparatus for and method of, treating viral infections. The apparatus comprises at least one means for emitting divergent, narrow bandwidth electromagnetic radiation centred at 1072nm; and at least one means for emitting visible green-cyan light in the range 470-560 nm.

Description

APPARATUS FOR AND METHOD OF TREATING VIRAL. INFECTIONS
This invention relates to en apparatus that emits both electromagnetic radiation centred around 1072nm and visible tight and method of treating viral infections, in particular, but not exclusively, Herpesvfridae infections.
BACKGROUND
There are at least eight herpesvirus types that infect humans: herpes simplex viruses 1 and 2, varicella-zoster virus, E8V (Epsteln-Berr virus), human cytomegalovirus, human herpesvirus 6, human herpesvirus 7. and Kaposi's sarcoma-associated herpesvirus, ail of which are extremely widespread among humans More than 90% of aduKs have been infected with at least one of these, and a latent form of the virus remains in most people.
Herpes simpiex viruses are categorized into two main types, herpes type 1 (HSV-1 . or oral herpes) and herpes type 2 (HSV-2, or genital herpes) Most commonly, herpes type 1 infection causes sores around the mouth and Bps. although HSV-1 can cause genital herpes, most cases of genital herpes infection are caused by herpes type 2. For many people with the herpes virus, which can go through periods of being dorman.t attacks (or outbreaks) can be brought on by the following conditoi ns general illness (from mid illnesses to serious conditions), fatigue, physical or emotional stress, irnrnunosunnression due to AIDS or such medications as chemotherapy or steroids. Irauma to the affected area, including sexual activity and menstruation. Furthermore it Is known that UV 8 light is a potent stimulus for inducing reactivation of latent herpes simpiex virus (HSV) infections. When an individual is first infected with herpes and exhibits active symptoms, the duration of the primary outbreak will be the worst and most painful and can take 3 to 6 weeks to resolve Subsequent recurrent outbreaks wilt be less severe, typically lasting 3 to 14 days and the frequency will become farther and farther apart with each recurring attack.
Electromagnetic radiation is characterized by its wavelength and its intensity. When the wavelength is within the visible spectrum (approximately from 390nm to 700nm) it is known as "visible light". Electromagnetic radiation less than 300nm is ultraviolet and wavelength greater than 1 ,0O0 are in the infrared region
Low level light therapy (LLLT) in the red region (d35-700nm) has been suggested as an alternative to current medications for accelerated rveaSng. reducing symptoms and A hand held device that could reduce the pain level, provide symptomatic relief, reduce the length of a herpetic infection outbreak and reduce the interval frequency between outbreaks would offer immediate advantage to individuals afflicted with herpetic infections.
BRIEF SUMMARY OF THE DISCLOSURE
According to a first aspect of the invention there is provided a hand-held battery operated electromagnetic radiation therapy device comprising:
(i) a housing for accommodating the battery:
(ii) an interface region comprising a surface for accommodating at least one means for emitting; divergent narrow bandwidth electromagnetic radiation centred at 1072nm: and at least one means for emitting visible green-cyan light in the range 470-580 nm.
wherein the device is capable of producing, at the site bei ng treated, a radiation intensity of at least 50 uμWatts/cm2 and up to 2 watts/cm2
Preterabiy, the electromagnetic radiation and the visible Merit are pulsed so that they are out of phase so that the electromagnetic radiation centred at 1072 nm is only emitted when the visible light is not emitted.
Preferably, the device includes a frequency modulator for phasing the at least one visible iignt emitting source and the at least one means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm so thai I he visibie light from the at least one visible light emitting source is pulsed out of phase with the infrared light.
Preferably, the device has a bandwidth around 120 nm and the half angle divergence of the electromagnetic radiation is in the range 15° to 45 °.
Preferably, the device further includes any one or more of the following features:
(I) means for fixing the intensity of the radiation within a pre- determined range.
(II) an output monitor with a visible display Indicating correct function of the device both for intensity and wavelength: (iii) means for controlling the duration of the application of the therapy.
Preferably, the at least one means of the means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm is a solid state light emitting device selected from the group comprising soBd state light emitting diodes (LEDs) or gas discharge devices or a laser diode device.
Preferably, the means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm Includes a PN junction arranged to emit radiation with a wavelength centring at. or about. t072nm.
Preferably, the pulsed electromagnetic radiation is applied at a frequency/repetition rate in the range 300-800 Hz and more preferably at 600Hz. Preferably, the at least one means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm is positioned at a substantially central position on the surface of the interface region and a plurality of means for emitting visible green-cyan light in the range 470-560 nm are positioned around the 1072nm emitter. Preferably, the device further includes one or more means for emitting visible light selected from the group comprising red light in the range 700-635 nm, orange light In the range 635- 590nm: yellow fight in the range 590-560nm and blue light in the range 405-470nm.
It win be appreciated that the design of the interface region surface may comprise a number of one means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm in addition to a number of means for emitting visible green/cyan light in addition to a number of means for emitting other visible lights in the blue, yellow and amber range. Preferably, the minimum pulse width for 1072 nm emission is 300 milliseconds.
According to a further aspect of the invention there is provided a method for treating and/or improvlngbody tissues wherein said body tissue has a herpetic Infection, the method comprising:
exposing said tissue to divergent electromagnetic radiation at a wavelength centred at 1072 nm so as to coincide with peak transmissions of a water molecule and visible green/cyan light in the range 470-560 nm: and
selecting a radiation intensi ty for the electromagnetic radiation capable of producing, at the site of the tissue, a radiation intensity of at least 50 μ Watts/cm2 up to 2 Watts/cm2
The method includes exposing herpetic viralty infected tissue to the selected electromagnetic radiation and visible light resulting in alleviation of the herpetic viral infection.
Preferably, the treatment period is between 3 to 10 minutes and may be repeated several times a day until the symptoms of the infection are alleviated
BRIEF DESCRIPTION OF THE DRAWINGS
Embodiments of the invention are further described hereinafter with reference to the accompanying drawings, in which:
Figure 1 is a plan view of one arrangement of the light emitting means on the surface of the interface region.
Figure 2 is a plan view of a different embodiment of Figure 1.
Figure 3 is a plan view of a yet further embodiment of Figure 1.
Figure 4 is a side view of the device of the present invention
DETAILED DESCRIPTION
Figure 1 shows the surface (1 ) of the interface region, tno surface is surrounded by wall (2) which is raised so that the Interface surface is protected and in use is kept away from direct skin contact Arranged on the surface (1) in a subsiantially centrally position is a means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm (3) and arranged around the periphery are a number of blue visible light emitting means (4a) In use. item (3) will be on when items (4a) are off, the sequence of on/off can
go clockwise or anticlockwise and alternated between the 1072nm emitter and one of the peripheral green/cyan light emitters In the embodiment depicted in Figure 2 there are provided two 1072 nm emitters (3) although the number can be more end is not intended to limit the scope of the application . Surrounding items (3) there ere provided visible green/cyan emitters (4 a) and other visible light emitters (4b). The (4b) emitters can be red. orange, yellow or blue and could in some embodiments can be a combination of one, two, three or four different colours or they may be duplicated colours wnlch pulse synchronously or individually in sequence and out of phase with the 10 72nm emitter. Figure 3 shows a yet further embodiment where a series of visible light emitters are green/cyan (4a) plus any other visible light (4t>. 4c).
With reference to Figure 4 there is shown the hand held device (A ) of the present invention. The device comprises a body (5) which accommodates a battery and a panel (6) which has a means for turning the device on and off and win oh may also comprise a display for assessing duration intensity and other parameters of the treatment.
A typical regimen for light exposure, when using. 1072nm and green/cyan light is for four minutess total of at least 300 ms of 1072nm alternatively with at ieast 300 ms of green/cyan light
A typical regimen cycle for multiple light exposure treatment time of around 4 minutes is:
I. 1072nm (300 ms)
II. Green/Cyan light (300ms)
III.10 72nm (300 ms)
IV. Blue light (300ms)
V, 1072nm (300 ms)
VI. Amber light (300ms)
Optionally red light may be included in the therapy
Throughout the description and claims of this specification, the words "comprise " and "contain" and variat ions of them mean "including but not limited to", and they are not intended to (and do not) exclude other moieties, additives, components, integers or steps. Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatibletherewftn. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings) and/or ail of the steps of any method or process so disclosed, may be combined in any combination except combinations where at least some of such features and tor steps are mutually exclusive. The invention is not restricted to the details of any loregoing embodimemts The invention extends to any novei one. or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one. or any novel combination of the steps of any method or process so disclosed
The reader's attention is directed to ail papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference.

Claims

1 A hand-held battery operated electromagnetic radiation therapy device comprising:
(i) a housing for accommodating the battery:
(ii) an in'erface region comprising a surface tor accommodating at least one means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm: and at least one means for emitting visible green/cyan tight in the range 470-560 nm,
wherein the device is capable of produ cing. at the site being treated, a radiation intensity of at least 50 μWatts/cm2 and up to 2 Watts/cm2 .
2. A device according to claim 1 wherein the electromagnetic radiation and the visible light are pulsed so that they are out of phase so thai the electromagnetic radialion centred at 1072 nm is only emitted when the visible light is not emitted.
3. A device according to either preceding claim including a frequency modulator for phasing the at least one visible light emitting source and the at least one means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm
4. A device according to any preceding claim -that has a bandwidth around 120 nm.
5. A device according to any preceding claim wherein the half angle divergence of the electromagnetic radialion is in the range 15° to 45 °.
6. A device according to any preceding claim further including any one or more of the following features:
ft) means for fixing the intensity of the radiation within a pre-determined range;
(iij an output monitor with a visible display indicating correct function of the device both for intensity and wavelength: and
(iU) means for controlling the duration of the application of the therapy.
7. A device according -to any preceding claim wherein the at least one means Tor emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm is a solid state light emitting device selected from the group comprising solid state light emitting diodes (LEDs) or gas discharge devices or a laser diode device.
8 A device according to any preceding claim wherein, the means for emttiing divergent narrow bandwidth electromagnetic radiation centred at10 72nm includes a PN junction arranged to emit radiation with a wavelength centring at. or about 1072nm.
9. A device according to any preceding claim wherein, the pulsed electromagnetic radiation is applied at a frequency/re petition rate in the range 300-800 Hz.
10. A device according to any preceding claim, wherein at least one means for emitting divergent narrow bandwidth electromagnetic radiation centred at 1072nm is positioned at a substantially central position on the surface of the interface region and a plurality of means for emitting visible green/cyan tight in the range 470-500 nm are positioned around the10 72nm emitter.
1 1. A device according to any preceding claim further including one or more additional means for emitting visible tight selected from the group comprising red light in the range 700-635 nm. orange light in the range 635-580nm; yellow light in the range 590- Seonm. and blue light in the range 405-470nm.
12. A device according to any preceding claim wherein the minimum pulse width for 1072 nm emission is 300 milHseconds
13 A method for treating and/or improving foody tissues wherein said body tissue has a herpetic infection, the method comprising:
exposing said tissue to divergent electromagnetic radiation at a wavelength centred at 1072 nm so as to coincide witti peak transmissions of a water molecule and visible green-cyan light in the range 470-560 nm: and
selecting a radiation intensity for the electromagnetic radiation capable of producing, at the site of the tissue a radiation fnte nsfty of at least SO u Watts/cm2 up to 2 Watts/cm2
14. A method according to claim 13 wherein the treatment period is between 3 to 10 minutes and is repeated several times a day until symptoms of the infection are alleviated.
PCT/US2019/016814 2018-02-06 2019-02-06 Apparatus for and method of treating viral infections WO2019157033A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862626794P 2018-02-06 2018-02-06
US62/626,794 2018-02-06

Publications (1)

Publication Number Publication Date
WO2019157033A1 true WO2019157033A1 (en) 2019-08-15

Family

ID=66166522

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2019/016814 WO2019157033A1 (en) 2018-02-06 2019-02-06 Apparatus for and method of treating viral infections

Country Status (1)

Country Link
WO (1) WO2019157033A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040193235A1 (en) * 2001-11-29 2004-09-30 Altshuler Gregory B. Multi-directional oral phototherapy applicator
WO2006134339A1 (en) * 2005-06-14 2006-12-21 Virulite Distribution Limited Use of electromagnetic radiation in the treatment of sensory organs
US20110178582A1 (en) * 2008-07-14 2011-07-21 Gordon Dougal Electromagnetic Radiation And Its Therapeutic Effect
US20160067086A1 (en) * 2014-09-09 2016-03-10 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040193235A1 (en) * 2001-11-29 2004-09-30 Altshuler Gregory B. Multi-directional oral phototherapy applicator
WO2006134339A1 (en) * 2005-06-14 2006-12-21 Virulite Distribution Limited Use of electromagnetic radiation in the treatment of sensory organs
US20110178582A1 (en) * 2008-07-14 2011-07-21 Gordon Dougal Electromagnetic Radiation And Its Therapeutic Effect
US20160067086A1 (en) * 2014-09-09 2016-03-10 LumiThera, Inc. Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments

Similar Documents

Publication Publication Date Title
KR100535159B1 (en) Improved Hand-held laser Device
CA3069276C (en) Antibacterial door knob
US20160101294A1 (en) Portable phototherapy apparatus for psoriasis
JP2015522315A (en) Device for use in medical treatment rooms
JP7136238B2 (en) Inactivation device and method
WO2019157033A1 (en) Apparatus for and method of treating viral infections
WO2019157011A1 (en) Apparatus for and method of treating viral infections
US20230001029A1 (en) Combined Light Disinfection Device
WO2019231505A1 (en) Apparatus for and method of treating viral infections
WO2019157018A1 (en) Apparatus for and method of treating viral infections
WO2022230359A1 (en) Ultraviolet light emission device, method for using ultraviolet light emission device, and ultraviolet light emission method
US20220096684A1 (en) Vehicle having disinfection system
ITBO20110017U1 (en) DEVICE FOR TREATING BY LIGHT THE BODY OF A LIVING BEING
US20240082441A1 (en) A light emitting system for disinfecting a target area
CN111920976A (en) Four-side irradiation far-short wave ultraviolet disinfection gallery and disinfection box chamber
US7514696B2 (en) Method for eliminating airborne microorganisms
US20220152236A1 (en) Multi-Band Germicidal Irradiation Apparatus
US20180178033A1 (en) Method and Apparatus for LED Biostimulation in Ocular Tissue
LP product guide
CN212475749U (en) Handrail area degassing unit and staircase
WO2022161884A1 (en) A system for uv-treatment in a containment
US20240100352A1 (en) Phototherapy device
US20210298164A1 (en) High Intensity Narrow Spectrum and Far UVC Protection Device
JP2024517601A (en) LED array for disinfection having different types of LEDs
JP2022054721A (en) Ultraviolet lamp

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19717384

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19717384

Country of ref document: EP

Kind code of ref document: A1